(Q43280569)

English

Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda

scientific article published on 3 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda (English)

1 reference

Europe PubMed Central

18 November 2017

0 references

1 reference

based on heuristic

inferred from title

Johan van Griensven

1

object named as

Johan van Griensven

1 reference

Europe PubMed Central

18 November 2017

2

object named as

Rony Zachariah

1 reference

Europe PubMed Central

18 November 2017

author name string

Freya Rasschaert

3

1 reference

Europe PubMed Central

18 November 2017

Jules Mugabo

4

1 reference

Europe PubMed Central

18 November 2017

Edi F Atté

5

1 reference

Europe PubMed Central

18 November 2017

Tony Reid

6

1 reference

Europe PubMed Central

18 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

3 September 2009

1 reference

Europe PubMed Central

18 November 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

18 November 2017

104

1 reference

Europe PubMed Central

18 November 2017

2

1 reference

Europe PubMed Central

18 November 2017

148-153

1 reference

Europe PubMed Central

18 November 2017

Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Adverse effects of highly active antiretroviral therapy in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

HIV viral load monitoring in resource-limited regions: optional or necessary?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Symptomatic hyperlactatemia: lessons learned using a point-of-care device in a health care center- and nurse-based antiretroviral program in Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.009

7 January 2021

Identifiers

10.1016/J.TRSTMH.2009.07.009

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43280569&oldid=1985533591"